ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,581,738 | -14.6% | 1,495,274 | -3.3% | 0.00% | -20.0% |
| Q2 2023 | $47,540,371 | -29.9% | 1,546,531 | -17.8% | 0.01% | -28.6% |
| Q1 2023 | $67,823,227 | +29.7% | 1,882,410 | +42.2% | 0.01% | +16.7% |
| Q4 2022 | $52,305,756 | -13.2% | 1,323,526 | -11.7% | 0.01% | -14.3% |
| Q3 2022 | $60,252,000 | -12.6% | 1,499,546 | -8.5% | 0.01% | -12.5% |
| Q2 2022 | $68,902,000 | -9.8% | 1,638,927 | -16.4% | 0.01% | +14.3% |
| Q1 2022 | $76,382,000 | -6.5% | 1,960,528 | -4.4% | 0.01% | -12.5% |
| Q4 2021 | $81,721,000 | +15.7% | 2,050,689 | +4.9% | 0.01% | +14.3% |
| Q3 2021 | $70,646,000 | +8.2% | 1,954,751 | +22.7% | 0.01% | 0.0% |
| Q2 2021 | $65,278,000 | +5.0% | 1,592,556 | +11.7% | 0.01% | 0.0% |
| Q1 2021 | $62,197,000 | +181.0% | 1,425,879 | +222.3% | 0.01% | +133.3% |
| Q4 2020 | $22,138,000 | +231.0% | 442,339 | +178.2% | 0.00% | +200.0% |
| Q3 2020 | $6,689,000 | +4450.3% | 158,998 | +5145.7% | 0.00% | – |
| Q2 2020 | $147,000 | – | 3,031 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |